Study Participants Needed
PHOENIX - Officials at the Arizona Research Center are searching for two trials of ALT-711 - an investigational drug used to reverse the effects of hypertension.
There are more than 60 testing sites nationally. Patients recruited will receive ALT-711 tablets or placebo one a day for six months.
To qualify, patients must be 50 years old or older, and have a systolic blood pressure of at least 150 mmHg and a diastolic blood pressure of less than 90 mmHg. Both male and female, diabetic and non-diabetic participants are being recruited.
For more information, contact Brook Irving at: 9602) 863-6363.
Balancing Freedom and Safety: When Public Health Mandates Are Necessary
January 9th 2025Public health mandates, such as lockdowns, masking, and vaccination, balance liberty and safety, ensuring critical protections during pandemics like COVID-19 while fostering long-term survival through science.
Avian Flu Risks in Veterinary Practice: Protecting Those on the Frontlines
January 6th 2025Veterinarians, technicians, and veterinarian infection preventionists face risks from H5N1 avian flu when handling farm animals or exposed wildlife. Learn key prevention strategies, PPE recommendations, and emerging challenges.
Understanding the True Threat: Richard Webby, PhD, on H5N1 Avian Flu and Its Human Impact
January 3rd 2025Richard Webby, PhD, the director of the World Health Organization (WHO) Collaborating Centre or Studies on the Ecology of Influenza in Animals and Birds, discusses the evolving dynamics of H5N1 avian flu, its variants, and the low risk to humans while emphasizing vigilance among health care professionals.
